BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces that the Data Safety Monitoring Board ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...

Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE) to current standard-of-care first ...

Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating ...

The event will be webcast live and can be accessed by visiting the Investors section of ALX Oncology's website at ...

BJC Healthcare has opened its first milk drop site at Missouri Baptist Medical Center. The site includes a freezer to store ...

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...

In this randomized controlled trial, in patients with PIK3CA-mutated advanced breast cancer, the addition of inavolisib to a ...

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to ...